*Moeka Tanabe1,2, Kazuo Kunisawa1, Imari Saito1, Aika Kosuge1, Hiroyuki Tezuka3, Tomoki Kawai1, Masaya Hasegawa1, Hisayoshi Kubota1,4, Kuniaki Saito2,5, Toshitaka Nabeshima2,6, Akihiro Mouri1,6
(1. Department of Regulatory Science for Evaluation & Development of Pharmaceuticals & Devices, Fujita Health University Graduate School of Health Sciences, Aichi, Japan., 2. Laboratory of Health and Medical Science Innovation, Fujita Health University Graduate School of Health Science, Aichi, Japan., 3. Department of Cellular Function Analysis, Research Promotion Headquarters, Fujita Health University, Aichi, Japan., 4. Division of Behavioral Neuropharmacology, International Center for Brain Science (ICBS), Fujita Health University, Aichi, Japan., 5. Advanced Diagnostic System Research Laboratory, Fujita Health University Graduate School of Health Science, Aichi, Japan., 6. Japanese Drug Organization of Appropriate Use and Research (J-DO), Aichi, Japan.)
キーワード:gut-brain axis, goblet cell, cystine, microglia
抄録パスワード認証
抄録の閲覧にはパスワードが必要です。パスワードを入力して認証してください。